Navigating Gaucher treatment denials and appeals

Gaucher disease is an inherited metabolic disorder that often requires lifelong treatment. There are two types of treatment available for Gaucher disease: enzyme replacement therapy (ERT) and substrate reduction therapy (SRT). Both therapies can be effective. 

However, because they are specialized medications, they can be expensive, and getting insurance approval isn’t always straightforward. If you’ve received a Gaucher treatment insurance denial, there are steps you can take to appeal the decision and advocate for the treatment you need.

Understanding the prior authorization process

One of the most common barriers to insurance coverage for specialized medications such as ERT and SRT is prior authorization. Some insurance plans require prior authorization, or advance approval, before they will cover certain treatments or medications.

Insurance companies use prior authorization for several reasons, including to:

• help control the cost of specialty medications by confirming they are medically necessary
• monitor prescriptions for controlled medications that are subject to additional regulations because of their potential for misuse
• help protect your safety by confirming that your healthcare provider has considered the medication, its potential side effects, and possible interactions with other medicines you take

If your medication requires prior authorization, the process typically involves the following steps:

• Your pharmacy, or the clinic dispensing your medication, lets your healthcare provider know that prior authorization is required.
• Your healthcare provider submits documentation to your insurance company explaining why the medication is medically necessary.
• Your insurance company reviews the request and lets you and your healthcare provider know whether coverage has been approved or denied.

How long prior authorization for Gaucher medications takes depends on your insurance plan. It may take anywhere from a day or two to several weeks.

Common reasons for ERT or SRT denials

Even though ERT and SRT are effective treatments for Gaucher disease, insurance companies may still deny coverage. Although receiving a denial can be frustrating, understanding the most common reasons for it may help you avoid errors and strengthen your appeal.

Insurance companies may deny coverage for ERT or SRT for the following reasons:

• There are errors in the prior authorization paperwork, such as an incorrect birthdate or member ID number.
• Your insurance plan limits how much medication it covers during a certain period.
• Your plan requires step therapy, meaning you must try other, less expensive medications before it will cover a specialty treatment.
• The medication is not included on your plan’s formulary, or list of covered medications.
• Your plan only covers generic medications.
• Your insurance company considers the medication experimental.
• Your insurance company determines that the treatment is not medically necessary.

Writing an effective letter of medical necessity

Appealing an ERT or SRT denial often involves a letter of medical necessity. Your healthcare provider submits this letter to explain why the treatment is medically necessary and request that your insurance company approve coverage or reverse its decision.

The letter may include the following:

• documentation confirming your diagnosis
• evidence that your healthcare provider has recently evaluated you and determined you still need the medication
• an explanation of why ERT or SRT is medically necessary
• information about how ERT or SRT is expected to benefit you
• an explanation of why other treatment options are not appropriate or sufficient

Your healthcare provider may also include medical literature, such as clinical trial results or recent scientific studies, to support the request. Although a licensed physician must write the letter of medical necessity, you may also choose to include your own letter describing how Gaucher disease affects your daily life.

Working with your doctor’s office on the appeal

Your healthcare provider’s office can be an important partner throughout the appeals process. Many practices have an insurance coordinator or patient navigator who can help you understand your insurance company’s requirements, submit paperwork, and file appeals.

Staying organized, keeping copies of insurance documents — such as previous approvals and your schedule of benefits — and staying in close communication with your healthcare provider’s office or pharmacist can also help you navigate the appeals process.

What to do if your final appeal is rejected

Many people living with rare conditions such as Gaucher disease find health insurance difficult to navigate. Several organizations provide insurance help for rare disease patients. For example, the Patient Advocate Foundation has many resources that may help you navigate health insurance, and the National Gaucher Foundation offers many resources and opportunities to connect with other people who have Gaucher disease.

If your insurance company continues to deny coverage for ERT or SRT, financial assistance may still be available. Patient support programs offered by the manufacturers of Gaucher medications, along with nonprofit organizations that help people with rare diseases, may be able to reduce treatment costs.

If you’re having trouble accessing your medication, ask your healthcare provider or pharmacist about these programs and any other financial assistance resources that may be available to you.

---

Gaucher Disease News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.